CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹14 Cr | ₹14 Cr | ₹13 Cr | ₹3.89 Cr | ₹3.89 Cr |
What is the latest Contingent Liabilities ratio of CONCORD BIOTECH ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹14 Cr |
Mar2023 | ₹14 Cr |
Mar2022 | ₹13 Cr |
Mar2021 | ₹3.89 Cr |
Mar2020 | ₹3.89 Cr |
How is Contingent Liabilities of CONCORD BIOTECH Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹14 Cr | 0.00 | |
Mar2023 | ₹14 Cr | 7.43 | |
Mar2022 | ₹13 Cr | 242.57 | |
Mar2021 | ₹3.89 Cr | 0.00 | |
Mar2020 | ₹3.89 Cr | - |
Compare Contingent Liabilities of peers of CONCORD BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CONCORD BIOTECH | ₹18,901.2 Cr | 2.6% | -12.3% | 6.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
CONCORD BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CONCORD BIOTECH | 2.6% |
-12.3% |
6.6% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses